Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective CDK 4/6 inhibitor cancer therapeutics

Selective CDK 4/6 inhibitor cancer therapeutics

US Patent 12319690 · Granted Jun 3, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors2025
Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors2025
Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors2025
Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors2025
Azithromycin and roxithromycin derivtives as senolytic drugs2025
Azithromycin and roxithromycin derivtives as senolytic drugs2025
Biomarkers and therapeutics for endocrine therapy resistance2025
Biomarkers and therapeutics for endocrine therapy resistance2025
Companion diagnostics for mitochondrial inhibitors2024
Companion diagnostics for mitochondrial inhibitors2024
Selective CDK4/6 inhibitor cancer therapeutics2024
Selective CDK4/6 inhibitor cancer therapeutics2024